LOMBARDI, CAROLINA
 Distribuzione geografica
Continente #
NA - Nord America 8.461
EU - Europa 3.668
AS - Asia 1.673
SA - Sud America 60
OC - Oceania 14
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.896
Nazione #
US - Stati Uniti d'America 8.311
CN - Cina 662
DE - Germania 626
SE - Svezia 624
IE - Irlanda 555
IT - Italia 554
SG - Singapore 505
RU - Federazione Russa 423
UA - Ucraina 344
HK - Hong Kong 266
GB - Regno Unito 193
CA - Canada 138
FI - Finlandia 109
VN - Vietnam 87
FR - Francia 56
DK - Danimarca 52
AT - Austria 39
IN - India 38
NL - Olanda 34
BR - Brasile 33
TR - Turchia 29
ID - Indonesia 26
JP - Giappone 19
BE - Belgio 14
AU - Australia 12
PE - Perù 10
IR - Iran 7
PL - Polonia 7
MX - Messico 6
PT - Portogallo 6
TW - Taiwan 6
AR - Argentina 5
CH - Svizzera 5
CL - Cile 5
CZ - Repubblica Ceca 5
EU - Europa 5
KR - Corea 5
EG - Egitto 4
ES - Italia 4
VE - Venezuela 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
DO - Repubblica Dominicana 3
JO - Giordania 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
BO - Bolivia 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
LY - Libia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
VC - Saint Vincent e Grenadine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
GD - Grenada 1
GE - Georgia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MU - Mauritius 1
OM - Oman 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.896
Città #
Ann Arbor 1.500
Fairfield 923
Woodbridge 671
Houston 554
Dublin 531
Ashburn 506
Chandler 478
Frankfurt am Main 473
Wilmington 464
Singapore 401
Jacksonville 371
Seattle 328
Cambridge 311
Dearborn 293
Hong Kong 259
New York 229
Princeton 214
Santa Clara 191
Milan 178
Nanjing 106
Lawrence 101
Altamura 90
Shanghai 80
Beijing 75
San Diego 68
Lachine 60
Dong Ket 45
Nanchang 42
Guangzhou 39
Shenyang 36
Vienna 36
Helsinki 32
Toronto 28
Andover 26
Hangzhou 26
Hebei 23
Jakarta 23
Boardman 22
London 22
Norwalk 22
Jiaxing 21
Belo Horizonte 18
Huizen 18
Edmonton 17
Tianjin 17
Hefei 16
Jinan 16
Kunming 16
Ottawa 16
Changsha 15
Falls Church 15
Lappeenranta 15
Washington 15
Brussels 14
Fremont 14
Rome 14
Egham 10
Ningbo 10
Zhengzhou 10
Los Angeles 9
Mountain View 9
Swansea 9
Taizhou 9
Verona 9
Kiev 8
Kocaeli 8
Montreal 8
Chicago 7
Paris 7
Sydney 7
Dallas 6
Inver Grove Heights 6
Lima region 6
Mumbai 6
Oxford 6
Sacramento 6
Turin 6
Chengdu 5
Fuzhou 5
Groningen 5
Lisbon 5
Mendota Heights 5
Perugia 5
Phoenix 5
Pioltello 5
University Park 5
Upper Marlboro 5
Ankara 4
Cairo 4
Chiswick 4
Esslingen am Neckar 4
Florence 4
Kilburn 4
Lima 4
Marche 4
Munich 4
Muskegon 4
Nürnberg 4
Polska 4
São Paulo 4
Totale 10.398
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 401
Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines 307
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 282
Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke 279
Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns 264
Blood pressure variability and obstructive sleep apnea. A question of phenotype? 230
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 203
High altitude exposure of three weeks duration increases lung diffusing capacity in humans 201
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 186
Effects of device-guided slow breathing training on exercise capacity, cardiac function, and respiratory patterns during sleep in male and female patients with chronic heart failure 182
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 181
Obstructive sleep apnoea treatment and blood pressure: Which phenotypes predict a response? A systematic review and meta-analysis 181
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: Data from HIGHCARE study on Mount Everest 177
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database 176
High-altitude hypoxia and periodic breathing during sleep: gender related differences 169
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure 168
Aging, High Altitude, and Blood Pressure: A Complex Relationship 167
Assessment and management of blood pressure variability. 165
Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study 160
Heart failure and sleep disorders 160
Is daytime siesta a harmful habit? 157
Autonomic cardiac modulation in obstructive sleep apnea: Effect of an oral jaw-positioning appliance 151
Time to rethink the management of underlying sleep disturbances in nondippers? 150
Sleep-disordered breathing among hospitalized patients with COVID-19 150
Continuous positive airway pressure increases haemoglobin O2 saturation after acute but not prolonged altitude exposure 148
Is intensified diuretic therapy an effective new treatment strategy in obstructive sleep apnea patients with uncontrolled hypertension? 148
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 147
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure 146
Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders 146
Accuracy of Different Types of Blood Pressure Measuring Devices at High Altitude. Data From Highcare-Alps Study 146
Diastolic dysfunction in controlled hypertensive patients with mild-moderate obstructive sleep apnea 145
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 144
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 144
Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide. 143
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 143
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 141
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 141
The European sleep apnoea database (ESADA) –report from 22 European sleep laboratories 140
Sleep and the cardiovascular system 140
Management of obstructive sleep apnea in Europe 139
Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and european hypertensive subjects: Data from the ARTEMIS study 137
Treatment of central sleep apnea in heart failure patients: Benefit or harm? 137
Periodic Limb Movement during Sleep, Sleep Related Breathing Disorders and Hypertension in the ESADA Cohort 137
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 137
Systemic hypertension in obstructive sleep apnea 136
Blood Pressure Variability: Assessment, Predictive Value, and Potential as a Therapeutic Target 136
Control of hypertension in nonsleepy patients with obstructive sleep apnea 135
Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure Patients 135
Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA) 135
Current challenges for hypertension management: From better hypertension diagnosis to improved patients' adherence and blood pressure control 135
Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial 135
Autonomic arousals in sleep related breathing disorders: a link between daytime somnolence and hypertension? 130
Glucose tolerance and weight loss in obese women with obstructive sleep apnea 130
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes 128
Sex and age differences in the relationship between sleep duration and hypertension 126
Acute high altitude exposure reduces lung diffusion without evidence of alveolar capillary membrane damage. Evidence from the HIGHCARE Alps Project. 126
Obstructive sleep apnea syndrome as a cause of resistant hypertension 126
Management of heart failure in the new era: The role of scores 126
Assessment and interpretation of blood pressure variability in a clinical setting 124
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 123
Wearable seismocardiography for the beat-to-beat assessment of cardiac intervals during sleep 122
Disturbi del sonno in una popolazione di studenti delle lauree sanitarie. Associazioni con lo stress, lavoro a turni e ripercussioni sulla performance accademica percepita 117
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 117
Sleepwalking in Italian operas: a window on popular and scientific knowledge on sleep disorders in the 19th century 115
Clinical presentation of patients with suspected obstructive sleep apnea and self-reported physician-diagnosed asthma in the ESADA cohort 115
Renin-Angiotensin-Aldosterone System Is Not Involved in the Arterial Stiffening Induced by Acute and Prolonged Exposure to High Altitude 114
Effects of slow deep breathing at high altitude on oxygensaturation, pulmonary and sistemi hemodynamics. 111
Combined exercise training in postmenopausal women: implications for vascular hemodynamics. 111
Obstructive sleep apnea syndrome and autonomic dysfunction 109
Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA) 109
Use of the Clinical Global Impression scale in sleep apnea patients – Results from the ESADA database 106
Obstructive sleep apnea syndrome: A cause of acute delirium 101
What are the causes of excessive daytime sleepiness in patients with sleep-disorderd breathing? 101
Recommendations for the management of patients with obstructive sleep apnoea and hypertension. 100
A patient-centric web-based approach to improve hypertension management: a lesson learned from postmenopausal women 100
Assessing the fractal structure of heart rate by the temporal spectrum of scale exponents: a new approach for detrended fluctuation analysis of heart rate variability 100
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment 99
Protocolli diagnostici e terapeutici di Medicina del sonno: esperienza in Medicina del Lavoro di un Centro Universitario/Ospedaliero 97
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort 97
Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA) 97
Cotinine and blood pressure levels: variability omitted once again 95
Weight and blood pressure changes in high vascular risk patients 94
Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure 94
Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apneas: a cross-sectional study 92
Baroreflex modulation during sleep and in obstructive sleep apnea syndrome. 90
Cap. 1: White coat hypertension definition, terminology and prevalence. 1-19. Cap. 2: Diagnostic approach to white coat effect and white coat hypertension. 21-50 Cap. 4: Predictive factors for white-coat hypertension. 61-78 89
Diabetes mellitus prevalence and control in sleep-disordered breathing: The European Sleep Apnea Cohort (ESADA) study 89
La strana storia dello sherpa e della bombola di monossido di carbonio: ovvero storia di un’avventura scientifica. Uno studio del Progetto HIGHCARE 2008 88
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk 81
Sleep patterns and high blood pressure: more evidence needed 77
Comment to the editorial by KS Park and EW Kang “Is only fixed positive airway pressure a robust tool for kidney protection in patients with obstructive sleep apnea?” 77
Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of the European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea 75
Obstructive Sleep Apnea Syndrome (OSAS) and cardiovascular system 75
Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database 75
Obstructive Sleep Apnea and Adherence to Continuous Positive Airway Pressure (CPAP) Treatment: Let’s Talk about Partners! 74
Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders 73
Chapter 11: Secondary hypertension: sleep apnea 70
Menopause and Sleep Apnea 67
Hypertension and atrial fibrillation in obstructive sleep apnea: Is it a menopause issue? 67
Nocturnal hypoxemia, blood pressure, vascular status and chronic mountain sickness in the highest city in the world 65
Totale 13.527
Categoria #
all - tutte 53.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.829 0 0 0 0 230 325 376 233 282 171 150 62
2020/20212.271 147 116 198 219 185 227 247 229 193 252 84 174
2021/20221.583 134 129 254 148 102 79 73 59 81 144 122 258
2022/20232.289 277 595 236 186 169 361 41 119 114 30 91 70
2023/20241.767 62 69 72 66 254 428 339 54 166 46 46 165
2024/20251.396 257 421 169 204 345 0 0 0 0 0 0 0
Totale 14.429